Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IMAX CORPIMAX · Entity 4276 | Director · Chief Executive Officer | August 18, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IMAX CORP
Report date August 18, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| common sharesSEC Table I · non-derivative | Direct | 665,002 |
Ending reported balance
After 2026-08-20 transaction · row 6
5 source rows · reconciled sequenceRow 2 · 2026-08-18 · Conversion · Acquired 151,253 · Balance 916,255 F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 3 · 2026-08-18 · Sale · Disposed 151,253 · Balance 765,002 F2: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 4 · 2026-08-19 · Conversion · Acquired 205,504 · Balance 970,506 F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 5 · 2026-08-19 · Sale · Disposed 205,504 · Balance 765,002 F2: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026. Row 6 · 2026-08-20 · Sale · Disposed 100,000 · Balance 665,002 |
| stock options (to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.90 · Expires 2027-01-03 | Direct | 1,181,158 |
Reported balance
After 2026-08-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-18 · Conversion · Disposed 151,253 · Balance 1,181,158 F3: These options were issued in 2017 and are set to expire on January 3, 2027. F4: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019. F5: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively. |
| stock options (to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.90 · Expires 2027-01-03 | Direct | 975,654 |
Reported balance
After 2026-08-19 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-19 · Conversion · Disposed 205,504 · Balance 975,654 F3: These options were issued in 2017 and are set to expire on January 3, 2027. F4: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019. F5: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively. |
| common shares (opening balance)SEC Table I · non-derivative | Direct | 765,002 |
Reported balance
Holding disclosure · report date 2026-08-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 765,002 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
F2: Represents the sale of converted common shares pursuant to a 10b5-1 Plan dated May 19, 2026.
F3: These options were issued in 2017 and are set to expire on January 3, 2027.
F4: The stock options became exercisable in nine installments: 39,640 on each of May 1, 2017, September 1, 2017, May 1, 2018, December 31, 2018, September 1, 2019 and December 31, 2019, and 39,639 on each of December 31, 2017, September 1, 2018 and May 1, 2019.
F5: This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 975,654, 231,562 and 665,002, respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2016 Filed Jan 5, 2017 21:15 UTC | IMAX CORP IMAX · Entity 4276 | Tax withholdingcommon shares | 7,733 | $31.40 | $242,816.20 |
DisclosureSEC source: 0001214659-17-000123 · marketforms-37493.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,309 F2 · shares: Mr. Gelfond is reporting 7,733 common shares withheld to satisfy his tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transaction. Read SEC document |
| December 31, 2016 Filed Jan 5, 2017 21:15 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversioncommon shares | 14,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-17-000123 · marketforms-37493.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 21:15 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 33,419 | $31.90 | $1,066,159.67 |
DisclosureSEC source: 0001214659-16-015316 · marketforms-37330.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,047 F2 · shares: Mr. Gelfond is reporting the sale of 33,420 common shares to satisfy his tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transaction. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:15 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversionrestricted share units · Derivative | 64,742 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-16-015316 · marketforms-37330.xml · derivative · entry 6 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,484 Underlying: common shares · 64,742 shares Expires 2019-01-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F1 · shares: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F1 · price: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F3 · balance_after: This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following this transaction will be 2,063,092; 340,325 and 156,147 respectively. Read SEC document |
| December 09, 2016 Filed Dec 13, 2016 21:15 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversioncommon shares | 64,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-16-015316 · marketforms-37330.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 21:00 UTC | IMAX CORP IMAX · Entity 4276 | Grantrestricted share units · Derivative | 195,846 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-16-014835 · marketforms-36991.xml · derivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,846 Underlying: common shares · 195,846 shares Expires 2020-01-31 F1 · security: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F1 · shares: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F1 · price: Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. F2 · derivative.exercise_date: The restricted share units vest and will be converted in seven installments: 65,280 on January 1, 2018; 21,761 on May 1, 2018; September 1, 2018; December 31, 2018; May 1, 2019; September 1, 2019 and December 31, 2019. F3 · balance_after: This represents the number of restricted stock units issued for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following this transaction will be 2,063,092; 405,067 and 124,824 respectively. Read SEC document |
| September 02, 2016 Filed Sep 6, 2016 20:15 UTC | IMAX CORP IMAX · Entity 4276 | Salecommon shares | 7,741 | $30.83 | $238,641.87 |
DisclosureSEC source: 0001214659-16-013583 · marketforms-36195.xml · nonDerivative · entry 5 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,724 F2 · shares: Mr. Gelfond is reporting the sale of 7,741 common shares to satisfy his legal tax withholding obligations in connection with the delivery of the converted 14,995 common shares. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:15 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversionrestricted share units · Derivative | 14,995 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001214659-16-013583 · marketforms-36195.xml · derivative · entry 6 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,995 Underlying: common shares · 14,995 shares Expires 2016-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Represents the conversion upon vesting of 14,995 restricted share units into common shares. Each restricted share unit represented a contingent right to receive one common share of IMAX Corporation. F1 · shares: Represents the conversion upon vesting of 14,995 restricted share units into common shares. Each restricted share unit represented a contingent right to receive one common share of IMAX Corporation. F1 · price: Represents the conversion upon vesting of 14,995 restricted share units into common shares. Each restricted share unit represented a contingent right to receive one common share of IMAX Corporation. F3 · balance_after: This represents the number of restricted stock units issued for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following this transaction will be 2,063,932; 209,221 and 124,824 respectively. Read SEC document |
| September 01, 2016 Filed Sep 6, 2016 20:15 UTC | IMAX CORP IMAX · Entity 4276 | Exercise / conversioncommon shares | 14,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-16-013583 · marketforms-36195.xml · nonDerivative · entry 4 GELFOND RICHARD L · CIK 0000944011 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the conversion upon vesting of 14,995 restricted share units into common shares. Each restricted share unit represented a contingent right to receive one common share of IMAX Corporation. F1 · price: Represents the conversion upon vesting of 14,995 restricted share units into common shares. Each restricted share unit represented a contingent right to receive one common share of IMAX Corporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.